Thank you for submitting your manuscript for consideration by The EMBO Journal. I would like to apologize for the delay associated with its evaluation, owed to the fact that the decision in this case was not a straightforward one and thus necessitated various further consultations within the editorial team. Three expert referees have assessed the study, and as you will see from their comments copied below they are somewhat divided in their overall opinions on the study. It is apparent that they all consider your study on orientation-specific thrombopoietin receptor signaling and its differential physiological outcomes potentially quite interesting; they however raise concerns that after your conceptually similar report focussing on the erythropoietin receptor a few years ago, more mechanistic understanding would be required at this stage. At the same time, all referees feel that stronger and convincing proof needs to be provided that the different fusion registers employed in the various chimeras indeed all differentially affect orientation in the juxtamembrane regions as presumed -and here we agree that this is an absolute key prerequisite for eventual publication in these pages. Additionally, the reports raise a number of specific other major issues that would need to be addressed, such as possible differences in receptor trafficking and early signaling events that could underlie the observed differences in downstream signaling (please see in particular referee 3's detailed comments on these aspects).
In the absence of decisive and substantial additional data to address these key concern, I am afraid I have to agree that the study is currently not a good candidate for publication in The EMBO Journal, also given the conceptual precedent from the EpoR work. However we do note that many of the points raised appear to be in principle addressable, which would potentially result in a much stronger study, and I would therefore be inclined to allow you the opportunity to resubmit a revised version of the manuscript. It is however clear that this will likely entail a considerable amount of further work and effort, and I would therefore understand if you were to decide to rapidly publish the study without major changes in a somewhat more specialized journal. I should also make clear that we would only be able to consider the study further if you should be able to present strong and definitive structural, biochemical or biophysical evidence to support that different receptor helix orientations can indeed be 'dialed' (as requested by ref 1 point 2, ref 2 point 2, and ref 3 point 5) -if these requests can not be satisfactorily addressed, then I am afraid you might be best advised to seek publication elsewhere.
Should you however be able to convincingly address this issue, as well as the other major points raised by referees 1 and 3, then we should be happy to consider a revised version further for publication. In this case, please be aware that it is our policy to allow only one single round of major revision, and that it is thus essential to diligently answer to all the major and minor points raised at this stage. Also, when preparing a letter of response, please bear in mind that this will form part of the Peer Review Process File, and will therefore be available online to the community in the case of publication (for more details on our Transparent Editorial Process initiative, please visit our website: http://www.nature.com/emboj/about/process.html). In any case, please do not hesitate to get back to us should you need feedback on any issue regarding this decision.
Yours sincerely, Editor The EMBO Journal _____ REFEREE REPORTS:
Referee #1 (Remarks to the Author):
The manuscript of Staerk et al. describes the use of chimeric TPO receptors, in which a helical dimerization domain is substituted for TPOR's ectodomain and fused to the TPOR TM/intracellular domains, to examine the role of TPOR subunit orientation in signal transduction. TPOR signal transduction was appraised in two factor dependent cell lines by monitoring proliferation and the phosphorylation of key signaling intermediates, and the study was extended to the mouse by employing transplantation of bone marrow cells retrovirally-transduced to express each chimeric receptor. This manuscript describes a carefully executed and thorough study, which greatly enhances our knowledge of the poorly understood process of TPOR activation. The conclusions are well supported by the data presented, although the manuscript would benefit from inclusion of the following:
1. Throughout the Results section, much data are "not shown" or "unpublished". These data should be included as supporting information, as much of these data represent important controls. 2. Similarly, details of the Brett et al. (in preparation) paper should be provided. In the absence of experimental data to demonstrate that the TPOR TM/JM region adopts a helical conformation, the onus is on the authors to demonstrate that a rotation of the dimerization domain is indeed transmitted via the TPOR TM to the JM region. The authors should include proof-of-principle experiments that if an insertion is made in the TM/JM junction to rotate the subunits relative to one another, the same outcome is observed if the helical register is modified within the coiled coil ectodomain. This is the approach used for GHR (Brown et al., Nat. Struct. Biol 2005) , where alanines where inserted at the end of the TM region to alter the helical register. Such an insertion would be expected to phenocopy the modifications within the coiled coil domain. 3. The authors study a deletion of the pentapeptide JM motif, KWQFP, but the logic for why this mutant was used in preference to the pathological W515K/L or a AAAAA substitution mutant is unclear from the manuscript. I would like to see a W515 mutant and a AAAAA mutant studied in BaF3 cells, at the very least, in order to validate the predictions made by computational modelling of the TM/JM region.
A number of minor modifications would improve readability of the manuscript: 1. The biological relevance of the relative rotations of subunits is not clearly introduced until Discussion (page 18). The potential importance of other interactors tuning TPOR signaling outcomes should be made clear in the Introduction. This is crucial to the reader gauging the importance of the work. 2. Introduction (page 5): clarify "different dimeric TpoR interfaces". The authors are referring to dimerization in the TM/JM region of TPOR, but this is not clear until later in the manuscript. 3. The design of the coiled-coil mutants is difficult to understand from the way it is presented. It is crucial to the reader understanding the work that this is more clearly conveyed in the revised manuscript. For instance, the black letters written above Figure 1B 's green text is confusing. In mutant I, the T represents a "c" register residue but it is labelled as a "d" residue. A clearer depiction could be accomplished using a schematic figure. The success of the manuscript hinges on the clarity of this section. 4. The number of times cells were washed should be stated in methods for "Assay for Tpoindependent growth" and the subsequent two subsections. What is the composition of lysis buffer? 5. Figure 1B legend. Last sentence is incomplete. 6. Figure 1D . How many replicates? What is the error for the experiment? 7. Numbering inconsistency within the manuscript. Y112 does not correspond to a residue within the full length TPOR. This is a very nice paper from Constantinescu on the role of receptor dimer orientation on signaling. The conclusions are that receptor dimer geometry can influence the type of downstream signaling. The authors use dimeric coiled coils fused to the TPO TM regions in different rotational registers to show that each orientation seems to have distinct downstream effects. The idea is that the different registers of the coiled coils propagate through the TM region to influence the positions of the intracellular signaling components like JAKS and STATS.
While this is an interesting result, it suffers from several weaknesses that I think preclude EMBO publication. First, this work is highly redundant to the work this group has done using similar methodologies on the EPO receptor, which also showed orientation specific signaling. Thus the principles here are not novel, and have also been published at length by the Klingmuller group (and that are not cited). This is a similar example to the EPO studies but in a different system. What is needed is deeper insight, not more examples.
The second major weakness is that dimeric zippers are used to dimerize the receptors, yet the structural speculations are completely unfounded and entirely speculative. The diagrams and helical wheel plots shown make it look like they can 'dial' the orientation of the receptor helices and ICD's in a controlled, near digital fashion. In fact, we have no idea what is happening beyond the zippers. The most that can be said is that making changes in the zipper constructs seems to effect signaling, but we have no idea what the mechanism is. I think these studies need to move beyond phenomenology to mechanism.
Referee #3 (Remarks to the Author):
In this paper, the role of orientation within the thrombopoietin receptor (TPOR) dimer was explored by using chimeric receptor variants, to which a left-handed coiled-coil domain was fused instead of the extracellular domain. The orientation was varied by removing 0-6 residues of the transmembrane domain. These constructs were expressed in different cell types and analyzed for constitutive signal activation using cell proliferation assays and transcriptional reporters. Moreover, activity of some constructs transfected into bone marrow progenitor cells was demonstrated. All but one of the chimeric tpoR were constitutively active, with slight variations of their activity in different assays, in contrast to what has been observed for the erythropoietin receptor (EPOR) Upon deletion of the cytosolic KWQFP motif, which was previously identified to be responsible for autoinhibition, similar activity for all constructs was observed. Based on these results and some modelling, the authors suggest a mechanism of autoinhibition meditated by the KWQFP motif. Though the data looks convincing on the first glance, I have several major concerns: 1. Upon fusion to the Put3 coiled-coil domain, the N-terminal capping residue of the TPOR transmembrane helix (probably E481) is removed. Thus, the C-terminal KALLL from in the Put3 domain is added to the transmembrane domain, which is now capped by the lysine changing the length and the composition of the transmembrane helix compared to wt TPOR. Moreover, different constructs have transmembrane helices with different length, which may have important consequences for trafficking and for signalling. It would be nice to show from a horizontal perspective, how the authors envision these different chimeras to be organized across the membrane. 2. The construct cc-TpoR-II is the only truly inactive construct. The Western blot in Fig. 1C demonstrates that this construct is the one which is expressed at a substantially lower level than all others. How do the authors explain the different bands in the Western blot? Glycosylation should not be the reason. The surface expression pattern very much agrees with the expression activity pattern. 3. The most interesting activities are early phosphorylation events including phophorylation of the receptor constructs (which can be readily pulled down through the HA tag). The assays done by the authors are much further downstream, so that an interpretation is difficult. Taking into account the rather different cell surface presentation (also relative to the expression levels) endocytosis may be very different, which could be ascribed to the different length of the TM helices. Since endocytosis is not only important for receptor downregulation, but also for signalling, this may also play an important role for differential activity of different variants. 4. Upon deletion of the KWQFP motif, now the C-terminal capping K of the transmembrane helix is removed and the transmembrane helix is shifted again (and the resulting capping residue is not readily identified). Also, the expression and cell surface expression of these constructs is not described. 5. The authors refer to solid state NMR experiments done with these transmembrane constructs, which are not shown. Without clear structural information on how the different variants are organized, the interpretation on the role of orientation in TPOR signalling are not justified. I know that some of these assays have been published previously (in very respectable journals), but I could not find convincing arguments there either. I would like to thank you and the reviewers for the very useful and constructive criticisms. We believe that we answered most of the concerns, both at the conceptual and at the technical level.
The two major concerns that were raised in the Editor's cover letter were 1) that manuscript is conceptually similar to our previous work on the EpoR and consequently more mechanistic understanding is needed of the orientation dependence of cytokine receptor activation, and 2) the need for "stronger and more convincing proof that the different fusion registers employed in the various chimeras all differentially affect orientation in the juxtamembrane regions as presumed". We first describe how we have addressed these major concerns in the revised manuscript and then individually address the reviewer comments below.
The first concern is addressed by revising the text to more clearly describe the differences in the signaling mechanisms between the EpoR and the TpoR. There are three key results that we emphasize that illustrate the mechanistic differences between these two cytokine receptors. i) We observe several dimeric interfaces that can promote signaling of TpoR, some of which are on opposite helical faces. In contrast, with EpoR we observed only a single activating interface. This observation in itself is a novel point that may have significant implications for signaling of TpoR at different cell differentiation stages during hematopoiesis. ii) Depending on the precise dimeric interface, differences are observed in the levels of receptor tyrosine phosphorylation and transcriptional activation by STATs and MAP-kinases. These signaling differences lead to amplification of different blood lineages. Moreover, we show that these differences produce different in vivo phenotypes, from normal platelet formation to myeloproliferative and myelodysplastic syndromes. The observation that we can control the development of different lineages and induce different in vivo phenotypes by modulating a single receptor, in a controlled fashion, is also a novel result.
iii) The five-amino acid amphipathic juxtamembrane motif, and specifically W508 (W515 in humans), imparts the observed signaling specificity to the TpoR dimers. We and others had previously shown that mutation of W515 induces constitutive activation. In the present study, we describe an important role for this tryptophan in the active state of the TpoR dimer.
We have directly addressed the second concern by using two different approaches: cross-linking and alanine insertions. First, we demonstrate the ability of the coiled coil to dial-in the different registers by showing ( Figure 1D ) that when L505 at the outset of the cytosolic domain (adjacent to the KWQFP insert) is replaced by a cysteine residue, only the cc-TpoR dimers, which are predicted to have this residue in the interface, form covalent o-PDM cross-links. This indicates that the predicted register is transmitted to L505 at the boundary between the transmembrane and the intracellular juxtamembrane region. Second, we show that alanine insertions at the intracellular end of the TM helix change the phenotype produced by the TpoR-cc constructs as predicted. The experiments are described in detail in the response to Reviewer 1.
Point-by-point answer to reviewers' comments and manuscript changes:
"This manuscript describes a carefully executed and thorough study, which greatly enhances our knowledge of the poorly understood process of TPOR activation. The conclusions are well supported by the data presented, although the manuscript would benefit from inclusion of the following"
We thank the reviewer for this encouragement.
"1. Throughout the Results section, much data are "not shown" or "unpublished". These data should be included as supporting information, as much of these data represent important controls."
We agree and now we show the data or add them to Supplemental Material. (Brown et al., Nat. Struct. Biol. 2005) , where alanines are inserted at the end of the TM region to alter the helical register. Such an insertion would be expected to phenocopy the modifications within the coiled coil domain."
"2. Similarly, details of the Brett et al. (in preparation) paper should be provided. In the absence of experimental data to demonstrate that the TPOR TM/JM region adopts a helical conformation, the onus is on the authors to demonstrate that a rotation of the dimerization domain is indeed transmitted via the TPOR TM to the JM region. The authors should include proof-ofprinciple experiments that if an insertion is made in the TM/JM junction to rotate the subunits relative to one another, the same outcome is observed if the helical register is modified within the coiled coil ectodomain. This is the approach used for GHR
We present polarized infrared spectra in Supplementary Figure 1 of the murine TpoR peptide (residues 481-522) corresponding to the TM domain along with the intracellular KWQFP insert. The spectra show that the TM region adopts helical secondary structure in membrane bilayers. We have previously published NMR data showing that the TM helix of TpoR extends through F510 (Staerk et al. 2006) . These data are provided (and referenced) to support the use of helical TM structure in the computational searches of low energy structures.
We have taken two approaches to demonstrate the ability of the coiled coil to dial-in the different registers. First, we show in Figure 1C that when L505 (512 by the human numbering of W515) is replaced by a cysteine residue, only the cc-TpoR dimers that are predicted to have this residue in the interface form covalent dimers after N,N'-1,2-phenylenedimaleimide (o-PDM) cross-linking. This indicates that the predicted register is transmitted to L505 at the boundary between the transmembrane and the intracellular juxtamembrane region.
Second, we added at the intracellular end of the TM domain one or several alanine residues on the background of cc-TpoR-II, cc-TpoR-IV and cc-TpoR-V and then compared signaling by these mutants with that of the cc-TpoR fusion proteins. When signaling via JAK2 is examined ( Figure 3C ), we observe that addition of alanine residues at the end of the TM domain phenocopies the effects of the similar predicted orientation by the original cc-TpoR proteins. As an example, ccTpoR-II becomes active if 1A is added (cc-TpoR+1A), as expected for cc-TpoR-I. While cc-TpoR-IV is highly active via JAK2, addition of 2A (cc-TpoR+2A) inactivates it, as would be predicted for cc-TpoR-II. Addition of one alanine to cc-TpoR-IV (cc-TpoR-IV+1A) leads to an active construct, like cc-TpoR-III, as predicted. Furthermore, as shown in Figure 3D , signaling via TYK2, which is specific only for cc-TpoR-III and cc-TpoR-VI, could now be induced by cc-TpoR-IV+1A or by ccTpoR-V+2A. Also as expected, adding 3A to cc-TpoR-V or 1A to cc-TpoR-II led to inactive proteins by the TYK2 system. Overall, the data in Figure 1C and 3C and D show that our system can dial-in the predicted dimeric interfaces and that the N-and C-termini of the TpoR TM sequence communicate through a rigid -helix.
With respect to addition of alanine residues at the C-terminus of the TM domain of the wild type TpoR, we performed those experiments, as we did for EpoR. It is important to note that while rotation of the GHR TM-JM domain by this approach suffices to activate receptor signaling (Brown et al., Nat. Struct. Biol. 2005 ), this was not found to be the case for EpoR. None of the attempts to activate EpoR by simple rotation or by flexible linkers in the cytosolic region worked, suggesting rotation is necessary, but not sufficient for activation. This also appears to be the case for TpoR, as rotation alone by inserting different numbers of alanines at the end of the TM domain does not lead to activation, except for a very weak activation by a 2A insertion. One possible explanation is that the alanine insertions weaken dimerization. This is in fact the reason that we employed the coiled coil system, which allows us to measure the orientation dependence of signaling. This system mimics the effect of ligand-induced dimerization in different orientations. Finally, I would agree that proving that Tpo induces a rotation in real time of the TM domain is the gold standard, but I believe our system allows us to decipher events related to each dimeric orientation, to identify the orientation that best mimics the normal Tpo signaling in vivo (cc-TpoR-I) and to identify those orientations that best resemble oncogenic receptor mutants.
"3.
The authors study a deletion of the pentapeptide JM motif, KWQFP, but the logic for why this mutant was used in preference to the pathological W515K/L or a AAAAA substitution mutant is unclear from the manuscript. I would like to see a W515 mutant and a AAAAA mutant studied in BaF3 cells, at the very least, in order to validate the predictions made by computational modeling of the TM/JM region."
We now also show in Supplemental Figure 3 that the W508K mutation (W515K in the human TpoR) activates all cc-TpoRs. In previous work we could see that the W515 mutations, especially W515K, induces stronger activation than the deletion of the motif. Thus, the presence of W515 is important for maintaining the receptor inactive and also for orientation-dependent signaling.
"A number of minor modifications would improve readability of the manuscript: 1. The biological relevance of the relative rotations of subunits is not clearly introduced until Discussion (page 18). The potential importance of other interactors tuning TPOR signaling outcomes should be made clear in the Introduction. This is crucial to the reader gauging the importance of the work."
We thank the reviewer for this important point. In the Introduction (page 4), we now present the notion of multiple possible interactors, interfaces and multifaceted roles of TpoR in hematopoiesis and in disease. Also, we introduce the concept that the oncogenic mutations also persistently dimerize the receptor, but that the interfaces of those dimers are equally unknown.
"2. Introduction (page 5): clarify "different dimeric TpoR interfaces". The authors are referring to dimerization in the TM/JM region of TPOR, but this is not clear until later in the manuscript."
We have changed the Introduction and corrected this point (page 5).
"3. The design of the coiled-coil mutants is difficult to understand from the way it is presented. It is crucial to the reader understanding the work that this is more clearly conveyed in the revised manuscript. For instance, the black letters written above Figure 1B's green text is confusing. In mutant I, the T represents a "c" register residue but it is labeled as a "d" residue. A clearer depiction could be accomplished using a schematic figure. The success of the manuscript hinges on the clarity of this section."
Figure 1 was remade and corrected and now we hope the presentation is better and conveys the message.
"4. The number of times cells were washed should be stated in methods for "Assay for Tpoindependent growth" and the subsequent two subsections. What is the composition of lysis buffer?"
This has now been added at page 25 (four times). Lysis buffer composition is now described at page 27.
"5. Figure 1B legend. Last sentence is incomplete." It is now corrected. "6. Figure 1D .
How many replicates? What is the error for the experiment?"
The FACS data are collected for 10,000 cells that are pools of transduced cells. Shown in one experiment of three with similar results. The error is <10%. (corrected now at page 45).
"7. Numbering inconsistency within the manuscript. Y112 does not correspond to a residue within the full length TPOR."
We now use the Y626 numbering both in the Figure, text and legend. Y626 is the correct numbering considering the full receptor sequence. The 112 numbering referred to the numbering when the first cytosolic residue (K507) was considered residue 1. 
"This is a very nice paper from Constantinescu on the role of receptor dimer orientation on signaling. The conclusions are that receptor dimer geometry can influence the type of downstream signaling. The authors use dimeric coiled coils fused to the TPO TM regions in different rotational registers to show that each orientation seems to have distinct downstream effects. The idea is that the different registers of the coiled coils propagate through the TM region to influence the positions of the intracellular signaling components like JAKS and STATS."
We thank the reviewer for the positive description of our results.
"While this is an interesting result, it suffers from several weaknesses that I think preclude EMBO publication. First, this work is highly redundant to the work this group has done using similar methodologies on the EPO receptor, which also showed orientation specific signaling. Thus the principles here are not novel, and have also been published at length by the Klingmuller group (and that are not cited). This is a similar example to the EPO studies but in a different system. What is needed is deeper insight, not more examples."
We agree that the methods used in this study are similar to those used in our previous work on the EpoR. The similar methods allow us to directly compare the two receptors in order to understand the very different biologic effects that they produce when activated. There are three key results that we now emphasize that illustrate the mechanistic differences between these two cytokine receptors. i) We observe several dimeric interfaces that can promote signaling of TpoR, some of which are on opposite helical faces. In contrast, with EpoR we observed only a single activating interface. This observation in itself is a novel point that may have significant implications for signaling of TpoR at different cell differentiation stages during hematopoiesis. ii) Depending on the precise dimeric interface, differences are observed in the levels of receptor tyrosine phosphorylation and transcriptional activation by STATs and MAP-kinases and now PI-3-kinase (Figure 4, Supplemental Figures 2 and 4, Table 1 ). These signaling differences lead to amplification of different blood lineages. Moreover, we show that these differences produce different in vivo phenotypes, from normal platelet formation to myeloproliferative and myelodysplastic syndromes. The observation that we can control the development of different lineages and induce different in vivo phenotypes by modulating a single receptor, in a controlled fashion, is also a novel result.
iii) The five-amino acid amphipathic juxtamembrane motif, and specifically W508 (W515 in humans), imparts the observed signaling specificity to the TpoR dimers. We and others had previously shown that mutation of W515 induces constitutive activation, but now we find an important role for this tryptophan in the active state of the TpoR dimer.
With respect to the previous work of others, such as the Klingmuller group, we now cite two papers on EpoR dimerization via TM domain from the Klingmuller group at page 20.
"The second major weakness is that dimeric zippers are used to dimerize the receptors, yet the structural speculations are completely unfounded and entirely speculative. The diagrams and helical wheel plots shown make it look like they can 'dial' the orientation of the receptor helices and ICD's in a controlled, near digital fashion. In fact, we have no idea what is happening beyond the zippers. The most that can be said is that making changes in the zipper constructs seems to effect signaling, but we have no idea what the mechanism is. I think these studies need to move beyond phenomenology to mechanism."
We are grateful for this comment, as it gave us the opportunity to build a number of mutants that allow us now to conclude that, at least until L505 in the cytosolic JM region, we can indeed dial in the predicted registers, and that the N-and C-terminal ends of the TM domain communicate through a continuous alpha-helix that we can control by junctions with the Put3 (on the N-terminus) and addition of alanines at the C-terminus. These data are shown in Figures 1C, 3C and D. We have taken two approaches to demonstrate the ability of the coiled coil to dial-in the different registers. First, we show in Figure 1C that when L505 (512 by the human numbering of W515) is replaced by a cysteine residue, only the cc-TpoR dimers that are predicted to have this residue in the interface form covalent dimers after N,N'-1,2-phenylenedimaleimide (o-PDM) cross-linking. This indicates that the predicted register is transmitted to L505 at the boundary between the transmembrane and the intracellular juxtamembrane region.
Second, we added at the intracellular end of the TM domain one or several alanine residues on the background of cc-TpoR-II, cc-TpoR-IV and cc-TpoR-V and then compared signaling by these mutants with that of the cc-TpoR fusion proteins. When signaling via JAK2 is examined ( Figure  3C ), we observe that addition of alanine residues at the end of the TM domain phenocopies the effects of the similar predicted orientation by the original cc-TpoR proteins. As an example, ccTpoR-II becomes active if 1A is added (cc-TpoR+1A), as expected for cc-TpoR-I. While cc-TpoR-IV is highly active via JAK2, addition of 2A (cc-TpoR+2A) inactivates it, as would be predicted for cc-TpoR-II. Addition of one alanine to cc-TpoR-IV (cc-TpoR-IV+1A) leads to an active construct, like cc-TpoR-III, as predicted. Furthermore, as shown in Figure 3D , signaling via TYK2, which is specific only for cc-TpoR-III and cc-TpoR-VI, could now be induced by cc-TpoR-IV+1A or by ccTpoR-V+2A. Also as expected, adding 3A to cc-TpoR-V or 1A to cc-TpoR-II led to inactive proteins by the TYK2 system. Overall, the data in Figure 1C and 3C and D show that our system can dial-in the predicted dimeric interfaces and that the N-and C-termini of the TpoR TM sequence communicate through a rigid -helix.
Because our cc-TpoR dimers do induce different effects, from different signaling (see new Figure  4 ), to different transcriptional activity (Figure 3, Supplemental Figures 2 and 4) and different in vivo effects (Figure 5 ), we believe we link orientation, position of juxtamembrane residues, to phosphorylation of cytosolic Y626, activation of downstream pathways and biologic function.
In this paper, the role of orientation within the thrombopoietin receptor (TPOR) The Put3 coiled-coil chimera are expressed as single TM helix proteins with the positively charged RRLR sequence following the KWQFP insert serving as the "stop translocation" signal. As a result, the topology of the constructs will be that of a Type 1 membrane protein with the N-terminus on the extracellular side of the membrane. The Put3 domain provides a strong dimerization motif. The experimental design relies on dimer formation to reduce helix tilt due to any hydrophobic mismatch with cellular membranes as the proteins traffic from the ER through the Golgi to the plasma membrane. The cell surface expression levels are reduced compared to wild-type TpoR (see Figure  1 ), but the relative expression levels are comparable, as would be expected if the organization across the membrane is similar.
To show that the N-and C-termini of the TM sequence can communicate through a rigid TM helix, we undertook an alanine insertion approach in which we changed the register of the JM domain by insertion of one or more alanines at the C-terminal end of the TM helix ( Figures 3C and D) -please see answers to Reviewers 1 and 2.
We also show that the position of JM residue L505 is correctly oriented by the coiled coil fusions as wedescribe, based on mutation of this residue by cysteine and o-PDM induced cross-linking ( Figure  1C ).
Thus, we believe we provide biochemical evidence showing that the coiled coil correctly orients the TM and JM domains, and that insertions at the end of the TM domain act exactly as predicted on the cc-TpoR fusion proteins. With respect to the tilt angle, and possibility of shifts in membrane, we cannot with the current technology absolutely rule out such effects, but all available data suggest that the TM domain is helical including in the cc-TpoR-II or cc-TpoR-V constructs. We have repeated many times the expression assessments and cc-TpoR-II is expressed at comparable levels with cc-TpoR-III, which is fully active. In Figure 1C one can observe that indeed while cc-TpoR-II was lower than cc-TpoR-IV, it did form dimers when L505 was mutated to Cys, while cc-TpoR-IV did not. Forced overexpression of cc-TpoR-II at levels higher than the others still does not result in activation. In the new Figure 4 , we study in detail the ability of cc-TpoR proteins to signal by phosphorylation of cytosolic Y626, to activate the various downstream pathways, and to recycle to the cell surface. The ability to signal is directly proportional to phosphorylation of Y626. cc-TpoR-II is clearly unable to induce this event and also could not induce activation of STAT3 and STAT1. "4. Upon deletion of the KWQFP motif, now the C-terminal capping K of the transmembrane helix is removed and the transmembrane helix is shifted again (and the resulting capping residue is not readily identified). Also, the expression and cell surface expression of these constructs is not described."
We now examined signaling by the W515K mutant of cc-TpoRs (W508K), where the capping K514 residue is maintained. This mutation also activates the receptor from all interfaces, suggesting that it is not the shift that triggers activation. We are working in parallel on biophysical measurements of peptides corresponding to the TM domain of the TpoR. The reference to polarized IR and NMR studies was to justify modeling of the TM domain as an -helix. We now include the IR data in the Supplementary Figure 1 . The IR data show that the TM sequence is helical and oriented roughly parallel to the membrane normal. Our previous data (Staerk et al. 2006) showed that the helix extends to F510.
We agree that the full structures of the Put3-TpoR-cc constructs would provide the most compelling demonstration for how the helices are oriented. However, to illustrate that we can in fact dial-in orientations using the coiled-coil domain, we have included new data based on cross-linking and alanine insertions (see Figures 1C, 3C and D) . Thank you for submitting your revised manuscript for our consideration. Two of the original referees have now assessed it once more, and I am happy to inform you that they consider their concerns satisfactorily addressed and the paper sufficiently strengthened to warrant publication in The EMBO Journal.
Before we will be able to proceed with formal acceptance of the study, there remains however one important issue I need to ask you to address. On conducting the routine pre-acceptance CrossCheck procedure, it has come to our attention that the manuscript text contains several passages that are nearly verbatim copies of passages from two of your previous, related publications (Seubert et al Mol Cell 2003 and Staerk et al Blood 2006) . With regard to the former publication, the whole paragraph on 'Computational Searches' in the current Methods section seems to be largely carried over from it; while sections from the Staerk et al paper have been taken over not only throughout the Method section but also in the Introduction (1st & beginning of 2nd paragraph, end of 3rd paragraph) and Discussion (2nd and especially 3rd paragraph) sections. I hope you understand that in accordance with current research integrity standards, these substantial text identities could be considered a form of self-plagiarism were they to be published in this form. I therefore need to kindly ask you to modify the relevant passages; in this respect, slight rephrasing should be sufficient in the Methods section, while the Introduction and especially Discussion parts -which express intellectual content -will need more significant rewriting to clearly differentiate them from your earlier publications.
I am therefore returning the manuscript to you once more, to allow you to modify the manuscript in a final round of text revision. Once we will have received an adequately re-written manuscript, we should then be able to proceed with formal acceptance and publication of the study. If you have not already done so, please complete and include also the relevant license forms at this stage, in order to expedite the production process.
Yours sincerely, Editor
The EMBO Journal _____ REFEREE REPORTS:
The authors have adequately addressed the concerns that were raised as part of the initial review and the manuscript is now acceptable for publication.
Staerk et al. have carefully addressed the concerns from all reviewers. They provide substantially more experimental evidence, which supports their claim of orientation-specific signaling by the Tpo receptor. Further explanations given in the response to the reviewers are convincing and these also have been incorporated into the main manuscript. This is indeed a novel and very exciting aspect of cytokine signaling with a high impact in this field. From my point of view, this paper now can be published in EMBO Journal as it is.
2nd Revision -authors' response 03 August 2011
Please find enclosed the revised manuscript "Orientation-dependent signaling by thrombopoietin receptor dimers"
The text has been revised according to your last letter, in order to avoid any overlap with any of our previously published manuscripts with respect to Material and Methods, Introduction or Discussion.
